News
NXSCF
0.016
NaN%
--
Next Science to Delist from ASX After Shareholder Approval
TipRanks · 02/11 00:49
Next Science Confirms Capital Return and Sets ASX Delisting for 11 February
TipRanks · 02/10 05:30
Next Science Amends Payment Date for Approved Capital Return
TipRanks · 02/02 00:58
Next Science Pushes Back Capital Return Payment as It Nears ASX Exit
TipRanks · 01/30 09:21
Next Science to Return Cash Capital to Shareholders Following Approval
TipRanks · 01/28 04:17
Next Science Investors Back Capital Return and ASX Delisting
TipRanks · 01/28 00:37
Next Science Details Cash Position and Capital Return Plan After Asset Sale
TipRanks · 01/27 22:49
Next Science Director Harry Thomas Hall IV Steps Down but Retains Shareholding
TipRanks · 01/07 05:37
ASX Suspends Next Science Shares Over Insufficient Operations
TipRanks · 01/01 23:47
Next Science Sets Capital Return, Delisting Plan as CEO and CFO Resign
TipRanks · 12/23/2025 06:58
Next Science Moves to Delist from ASX and Return Capital After Asset Sale
TipRanks · 12/23/2025 02:38
Next Science Wins ASX Waiver to Enable Capital Return After Asset Sale
TipRanks · 12/23/2025 02:27
Next Science Ltd Announces Cessation of Securities
TipRanks · 09/22/2025 00:58
More
Webull provides a variety of real-time NXSCF stock news. You can receive the latest news about Next Science through multiple platforms. This information may help you make smarter investment decisions.
About NXSCF
Next Science Limited is an Australia-based medical technology company. The Company focuses on enhancing patient outcomes, empowering physicians, and driving healthcare innovation through education, research, and cutting-edge product development. Its Durable Medical Equipment (DME) Wound Care includes advanced wound care solutions delivered through partnerships with DME providers, particularly in the United States home health and outpatient settings.